Lynn Kirkpatrick
2022
In 2022, Lynn Kirkpatrick earned a total compensation of $622.6K as Chief Executive Officer at Ensysce Biosciences, a 116% increase compared to previous year.
Compensation breakdown
| Option Awards | $214,914 |
|---|---|
| Salary | $392,500 |
| Other | $15,195 |
| Total | $622,609 |
Kirkpatrick received $392.5K in salary, accounting for 63% of the total pay in 2022.
Kirkpatrick also received $214.9K in option awards and $15.2K in other compensation.
Rankings
In 2022, Lynn Kirkpatrick's compensation ranked 4,000th out of 5,760 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 30.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,000 out of 5,760 | 31st |
Division Manufacturing | 2,262 out of 3,136 | 28th |
Major group Chemicals And Allied Products | 1,096 out of 1,422 | 23rd |
Industry group Drugs | 1,029 out of 1,323 | 22nd |
Industry Pharmaceutical Preparations | 753 out of 969 | 22nd |
Source: SEC filing on July 13, 2023.
Kirkpatrick's colleagues
We found three more compensation records of executives who worked with Lynn Kirkpatrick at Ensysce Biosciences in 2022.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021